Industry Veterans Launch MOMENTUS Biopharma Consulting

Nov 6, 2025
Scott Roberts and John Czekanski have launched MOMENTUS Biopharma Consulting, a strategic firm leveraging AI and technology to support biopharma clients across the therapeutic lifecycle, according to a press release.

Announced in a press release, industry leaders Scott Roberts and John "Zeke" Czekanski have launched MOMENTUS Biopharma Consulting, a strategic consulting firm focused on supporting biopharma companies through the therapeutic lifecycle. The company is headquartered in Lantana, Florida, with an additional office in Boston, Massachusetts.

MOMENTUS aims to integrate artificial intelligence and new technologies with human expertise to offer value-driven strategies for its clients. The firm provides consulting services that combine subject-matter knowledge with flexible, cost-effective solutions.

Roberts, serving as Chief Strategy Officer and Managing Partner, brings over 25 years of experience in healthcare and global value consulting, with previous roles at Biogen, Merck, and Roche. Czekanski, the company's CEO, previously co-founded Citrus Health Group and has held senior positions at Merck & Co., Cardinal Health, and the Fishawack Group of Companies.

The founders stated that MOMENTUS was created to address increasing industry complexity and regulatory challenges by providing targeted insights and strategic guidance to accelerate the approval and adoption of new therapies.

We hope you enjoyed this article

Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.

Also, consider following us on social media:

Free newsletter

Life AI Weekly

Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.

Whitepaper

Tensordyne Napier: What If One Rack Could Do the Work of Nine?

Tensordyne

This Tensordyne whitepaper presents Napier, an inference-focused AI processor and rack-scale system based on the company’s TDN Math logarithmic number system. It examines infrastructure requirements for large mixture-of-experts and agentic models, compares major inference architecture approaches, and details the TDN AIP processor, TDN72 pod, TDN Link fabric, and Napier Ultra configuration. The paper reports simulation-based performance, cost, and accuracy-validation results, including Tensordyne’s projected comparison of one Napier rack with a nine-rack Nvidia Rubin plus Groq deployment; the chip is reported as taped out and in fabrication.

Read more
Free, six days a week

Daily AI Brief: the AI news that matters, in your inbox.